The MOLES acronym, scoring system and protocol for managing patients with melanocytic choroidal...

CET
1
11 December 2020
Volume 21, Issue 4

This paper describes a new algorithm - MOLES – to distinguish choroidal naevi from melanomas.

Domains covered

Professionalism Clinical practice

Choroidal naevi can be difficult to distinguish from melanomas, meaning many patients with benign tumours are often referred to hospital eye clinics while urgent treatment of those with melanoma is delayed. Early treatment of choroidal melanoma maximises any opportunities for conserving vision and the eye, possibly preventing metastatic death in some patients. The author describes a new algorithm - MOLES - to highlight the most important indicators of malignancy. Against a backdrop of increasing use of telemedicine and the increasing scope for transferring more of the management of these patients to optometrists in the community, the author suggests that this new system may make it possible for a clinician to diagnose tumours remotely, without the patient having to attend a hospital eye clinic.

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Following the announcement by the Secretary for Health that the isolation period for people who test positive for COVID-19 will be cut to five full days in England, NHSE has confirmed this will apply in primary care settings.

UKHSA confirms that changes to the self-isolation period following Covid exposure applies to healthcare workers

The College issues advice following the Prime Minister's announced that the UK would return to COVID Alert Level 4.